The pathology of primary progressive multiple sclerosis (Q34625041)

3 August 2017

1 reference

title

The pathology of primary progressive multiple sclerosis. (English)

1 reference

primary progressive multiple sclerosis

3 August 2017

main subject

0 references

0 references

0 references

W Brück

1

1 reference

3 August 2017

C Lucchinetti

series ordinal

2

1 reference

3 August 2017

H Lassmann

series ordinal

3

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Multiple Sclerosis Journal

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

93-97

1 reference

Defining the clinical course of multiple sclerosis: Results of an international survey

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Oligodendrocytes in the early course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Axonal damage in acute multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Multiple sclerosis: Fas signaling in oligodendrocyte cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Identification of autoantibodies associated with myelin damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Monocyte/macrophage differentiation in early multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Programmed cell death, apoptosis and killer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Axonal pathology in multiple sclerosis. A historical note

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Axonal pathology in multiple sclerosis: relationship to neurologic disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

APOE genotype is a major predictor of long-term progression of disability in MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

A null mutation in the human CNTF gene is not causally related to neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

Primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS785RR

10.1191/1352458502MS785RR

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference